Health glaucoma

GLAUCOMA Before Hierapy for glaucoma is started, Hie primary healHi care provider thoroughly examines Hie ey The nurse reviews Hie primary health care provider s diagnosis and comments, takes a general patient health... 

GLAUCOMA When a cholinergic drug is used to treat glaucoma, die nurse checks the eye and die area around die eye daily for evidence of redness, inflammation, and excessive secretions, particularly if die ocular system is used. If secretions are present around die eye, the nurse removes them with a cotton ball or gauze soaked in normal saline or other cleansing solution recommended by die primary health care provider. 

The nurse notifies the primary health care provider immediately if eye pain increases or if it has not begun to decrease 3 to 4 hours after the first dose. If the patient has acute closed-angle glaucoma, the nurse checks the pupil of the affected eye every 2 hours for dilation and response to light. 

Carbonic anhydrase inhibitors During treatment for glaucoma, contact the primary health care provider immediately if eye pain is not relieved or if it increases. When a patient with epilepsy is being treated for seizures, a family member of the patient should keep a record of all seizures witnessed and bring this to the primary health care provider at die time of the next visit. Contact the primary healdi care provider immediately if die seizures increase in number. 

The share of the gross domestic product (GDP) fiar health care is now approximately 15% and is projected to grow to 18% in 2012.The 1.66 trillion U.S. health care expenditure in 2003 is projected to grow to 3.1 trillion in the year 2012. Annual health care costs have risen significantly from 204 per person in 1965 to 3,160 per person in 1992, with projections to be nearly 9,500 per person by the year 2008. Costs of glaucoma medications as a subset of ocular medications were recently reviewed. Though wide cost variance was present, other fectors, such as adverse effects, effectiveness, and ease of compliance, should be considered. 

In a 2002 report the World Health Organization reported that glaucoma has become the second leading cause of blindness worldwide. Overall, an estimated 12.3% of the world s 37 million blind had lost their sight because of glaucoma. 

Primary open-angle glaucoma (POAG) is a multifactorial chronic optic neuropathy with a characteristic acquired loss of optic nerve fibers. Cupping and atrophy of the optic disc occur in the absence of other known causes. Such damage develops in the presence of open anterior chamber angles. It produces characteristic visual field abnormalities. lOP is too high for the continued health of the eye. 

It is of note that in some embodiments, the specific cannabinoids isolated are those cannabinoids with suspected health benefits or suspected medicinal uses. For example, the cannabinoids and cannflavins may be used as anti-emetics, antinauseants, appetite stimulants, antiinflammatories, antioxidants, neuroprotectives, analgesics, suppressants for primary immune response, glaucoma remedies, antineoplastics, migraine headache remedies, menstrual pain remedies, anticonvulsants, anti-epileptics, or movement disorder remedies. The essential oils may be used for aromatherapy or as flavoring/scenting adjuvants. 

Glaucoma represents a significant health problem with estimates that between 2 to 9 percent of the adult population worldwide suffers from increased intraocular pressure. Current therapy include use of so-called beta-blockers . These drugs however are not effective for all patients and often result in undesirable side effects that include lowered pulse rate, asthma and gastrointestinal problems. It thus would be desirable to have a new means for treatment of glaucoma. 

Marijuana is a controversial, versatile weed that grows nearly everywhere in the world. There are no conclusive medical studies indicating that it is especially harmful to the health or the psyche. On the other hand, there is increasing evidence that it may have a number of medical uses, including treatment of glaucoma, asthma, migraine, congestion, epilepsy, convulsions and nerves. 

Merck has been actively restructuring its lines of business that were not significant to its financial position, liquidity, or operations. The company s intent was to focus its resources more fully on its core human health and pharmaceutical benefit services. This led to the development of products for the treatment of heart failure, high blood pressure, high cholesterol, depression, osteoporosis, glaucoma, asthma, and ulcers to name a few. The company has also been a leader in over-the-counter products (e.g., antacids). 

Health care professionals play an important role in improving compliance. This is particularly important if a drug is for serious conditions like epilepsy, glaucoma or hypertension, or is for infection because of the problem of drug resistance. 

Current pharmacotherapies are targeted to decrease the production of aqueous humor at the ciliary body and to increase outflow through the trabecular meshwork and uveoscleral pathways. There is no consensus on the best lOP-lowering technique for glaucoma therapy. General principles of patient management based on the patient s health, age, and ocular status include ... 

---